Completed Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne NCT05704114 Conditions Acne Vulgaris, Acneiform Eruptions, Cicatrix, +14 more Locations The Dermatology Institute of Boston — Boston, Massachusetts, United States View Trial Details
